Classification
- Anatomical main groupNNervous system
- Therapeutic subgroupN05
- Pharmacological subgroupN05B
- Chemical subgroupN05BA
- Chemical substanceN05BA01Diazepam
Where it is registered
Each register with its number of medicines and a few of them.
Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Health Canada · 38 medicines
CBG-MEB · 28 medicines
AIFA · 20 medicines
SFDA · 19 medicines · Historical list
HALMED · 17 medicines
FDA · 16 medicines
ALIMS · 9 medicines
HSA · 9 medicines
PHARMAC · 6 medicines
Show all 6MS · 6 medicines · Historical list
TFDA · 5 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
16 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Diazepam | United States | 10MG/2ML, 50MG/10ML, 5MG/ML … | injectable | Marketed | Galenicum HLTH |
| Diazepam | United States | 5MG/5ML | solution | Marketed | Chartwell Molecular |
| Diazepam | United States | 10MG/2ML, 2.5MG/0.5ML, 20MG/4ML | gel | Marketed | Navinta LLC |
| Diazepam | United States | 10MG, 2MG, 5MG | tablet | Marketed | Pioneer Pharms |
| Diazepam | United States | 5MG/ML | concentrate | Marketed | Chartwell Molecular |
| Diazepam | United States | 10MG/1SPRAY | Spray | Tentative approval | Padagis Israel Pharma LTD |
| Diazepam Intensol | United States | 5MG/ML | concentrate | Marketed | Hikma |
| Diastat | United States | 10MG/2ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 15MG/3ML (5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 2.5MG/0.5ML … | gel | Marketed | Bausch |
| Diastat Acudial | United States | 10MG/2ML, 20MG/4ML | gel | Marketed | Bausch |
| Valium | United States | 10MG, 2MG, 5MG | tablet | Marketed | Waylis Therap |
| Valtoco | United States | 10MG/SPRAY, 5MG/SPRAY, 7.5MG/SPRAY | spray | Marketed | Neurelis INC |
| Dizac | United States | 5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable | Not marketed | Pharmacia and Upjohn |
| Q-Pam | United States | 10MG, 2MG, 5MG | tablet | Not marketed | Quantum Pharmics |
| Valium | United States | 5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable | Not marketed | Roche |
| Valrelease | United States | 15MG | capsule, extended release | Not marketed | Roche |
| Libervant | United States | 10MG, 12.5MG, 15MG … | film | Tentative approval | Aquestive |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS, PHARMAC, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.